Ramberg H, Zucknick M, Barletta F, Davik P, Nybøen Å, Eri LM, Sivanesan S, Hole KH, Hompland T, Prestbakk SO, Gandaglia G, Bathen TF, Briganti A, Berge V, Austild Tasken K (2025)
Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients
Acta Oncol, 64, 1446-1454
DOI 10.2340/1651-226X.2025.43970, PubMed 41123130

Davis MF, Nikolavsky D, Cavalcanti AG, Flynn BJ, Gomez RG, Loh-Doyle J, Boyd SD, Horiguchi A, Hofer MD, Fisch M, Dahlem R, Martins FE, Campos-Juanatey F, Rusilko PJ, Holm HV, Simhan J, Angulo JC, Ludwig TA, Bernal JO, Higgins M, Vereecken S, Sterling J, Hays EK, Kolyvas PG, Stanisic A et al. (2025)
Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery Following Urethroplasty
J Urol, 101097JU0000000000004794 (in press)
DOI 10.1097/JU.0000000000004794, PubMed 41022035

Pharo H, Vedeld HM, Wahlqvist R, Lind GE (2025)
Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30
Eur Urol (in press)
DOI 10.1016/j.eururo.2025.07.028, PubMed 40998632